APPLICABILITY OF DIFFERENT TYPES OF MODELS IN HEALTH AND DISEASE

被引:5
作者
BALANT, L [1 ]
机构
[1] ZYMA SA,CH-1260 NYON,SWITZERLAND
关键词
D O I
10.3109/03602538409015058
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:75 / 102
页数:28
相关论文
共 23 条
[11]  
BALANT LP, 1983, DRUG FATE METABOLISM, P1
[12]  
BALANT LP, 1980, CONCEPTS DRUG META A, P311
[14]   DURATION OF ACTION OF PINDOLOL AND ITS RELATION TO PLASMA-LEVELS [J].
DAYER, P ;
BALANT, L ;
GORGIA, A ;
EBERLIN, JL ;
FABRE, J .
JOURNAL OF CLINICAL PHARMACY, 1979, 4 (02) :87-93
[15]   THE GENETIC-CONTROL OF BUFURALOL METABOLISM IN MAN [J].
DAYER, P ;
BALANT, L ;
COURVOISIER, F ;
KUPFER, A ;
KUBLI, A ;
GORGIA, A ;
FABRE, J .
EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 1982, 7 (01) :73-77
[16]   COMPARTMENTAL ANALYSIS .1. LINDE, A PROGRAM USING AN ANALYTICAL METHOD OF INTEGRATION WITH CONSTITUENT MATRICES [J].
ESTREICHER, J ;
REVILLARD, C ;
SCHERRER, JR .
COMPUTERS IN BIOLOGY AND MEDICINE, 1979, 9 (01) :49-65
[17]   PHARMACOKINETIC BASIS FOR INFLUENCE OF ROUTE OF ADMINISTRATION ON AREA UNDER PLASMA CONCENTRATION-TIME CURVE [J].
GIBALDI, M ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1969, 58 (12) :1477-&
[18]   INFLUENCE OF FIRST-PASS EFFECT ON AVAILABILITY OF DRUGS ON ORAL ADMINISTRATION [J].
GIBALDI, M ;
BOYES, RN ;
FELDMAN, S .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (09) :1338-&
[19]  
HUGUENIN P, 1978, SCHWEIZ MED WSCHR, V108, P206
[20]  
JAMES F, 1974, CERN COMPUTER 6000 S